Interestingly, the expressions of PCK1 and ABAT were increased, suggesting that PCK1 and ABAT were not only the prognostic biomarkers, but also the therapeutic targets of metformin and phenformin in T2DM and HCC. The gene discussed is ABAT; the disease is type 2 diabetes mellitus.